Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of the Efficacy of Maintenance Therapy by UFT or BCG for Superficial Bladder Cancer Against Recurrence in Urological Oncology Council of Northern Tokyo: EMBARK Study

NCT01082510 is registered in ClinicalTrials.gov with Urological Oncology Council of Northern Tokyo as lead sponsor.

NCT NCT01082510
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01082510 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of the Efficacy of Maintenance Therapy by UFT or BCG for Superficial Bladder Cancer Against Recurrence in Urological Oncology Council of Northern Tokyo: EMBARK Study
Lead sponsor
Urological Oncology Council of Northern Tokyo
Phase
Phase 3
Overall status
Unknown status
Start date
January 31, 2010
Completion date
December 31, 2019
Enrollment
288 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer